4 unchanged sentences
timely decisions regarding required disclosure.
−Removed: Ocuphire Pharma, Inc.
We designed and evaluated our disclosure controls and procedures recognizing that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance and
6 unchanged sentences
Under the supervision of and with the participation of our management, including our principal executive officer and principal financial officer, we evaluated the effectiveness of our disclosure
−Removed: controls and procedures, as such term is defined in Rules 13a-15(e) and 15(d)- 15(e) promulgated under the Exchange Act as of March 31, 2023.
+Added: controls and procedures, as such term is defined in Rules 13a-15(e) and 15(d)- 15(e) promulgated under the Exchange Act as of June 30, 2023.
Based on this evaluation, our principal executive officer and principal financial officer concluded that
−Removed: our disclosure controls and procedures were effective as of March 31, 2023.
+Added: our disclosure controls and procedures were effective as of June 30, 2023.
Changes in Internal Control Over Financial Reporting
−Removed: There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during the quarter ended March 31, 2023, that have materially
−Removed: affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
+Added: There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during the quarter ended June 30, 2023, that have materially affected,
+Added: or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
PART II – OTHER INFORMATION
+Added: Legal Proceedings
+Added: From time to time, we may be involved in various claims and legal proceedings relating to claims arising out of our operations.
+Added: We are not currently a
+Added: party to any legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our business.
+Added: Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs,
+Added: diversion of management resources and other factors.
+Added: Other than as set forth below, there have been no material changes in our risk factors previously disclosed in Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended
+Added: December 31, 2022.
+Added: You should carefully consider the risks and uncertainties described below and therein.
+Added: Unregistered Sales of Equity Securities and Use of Proceeds
+Added: Defaults Upon Senior Securities
+Added: Mine Safety Disclosures
+Added: Not applicable to our Company.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.